Rapid and Robust B Cell Depletion in Preliminary Results of a Phase 2 Study of Ublituximab, Novel Glycoengineered Anti-CD20 Mab, RMS Patients

Drug Category: Array
Conference Category: Array
Lead Author: Lovett-Racke A, Fox E et al.
Published Date: 26/05/2017
Download Link: /wp-content/uploads/2019/03/Final%202017%20CMSC%20Lovett-Racke%20TGTX.pdf
Download Text: Download
Popup Confirmation?:
site-sidebar-layout: default
ast-site-content-layout: default
site-content-style: default
site-sidebar-style: default
theme-transparent-header-meta: default
stick-header-meta: default
astra-migrate-meta-layouts: set
Scroll to Top